352 related articles for article (PubMed ID: 8621615)
21. Pharmacological profile of a novel, non-TZD PPARgamma agonist.
Chen X; Osborne MC; Rybczynski PJ; Zeck R; Yang M; Xu J; Zhou L; Cryan E; Tang Y; Demarest KT
Diabetes Obes Metab; 2005 Sep; 7(5):536-46. PubMed ID: 16050946
[TBL] [Abstract][Full Text] [Related]
22. Lipase maturation factor 1: its expression in Zucker diabetic rats, and effects of metformin and fenofibrate.
Forcheron F; Basset A; Del Carmine P; Beylot M
Diabetes Metab; 2009 Dec; 35(6):452-7. PubMed ID: 19854668
[TBL] [Abstract][Full Text] [Related]
23. The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment.
Liang Y; She P; Wang X; Demarest K
Metabolism; 2006 Oct; 55(10):1411-9. PubMed ID: 16979414
[TBL] [Abstract][Full Text] [Related]
24. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity.
Frederich RC; Löllmann B; Hamann A; Napolitano-Rosen A; Kahn BB; Lowell BB; Flier JS
J Clin Invest; 1995 Sep; 96(3):1658-63. PubMed ID: 7657836
[TBL] [Abstract][Full Text] [Related]
25. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.
Schwartz MW; Baskin DG; Bukowski TR; Kuijper JL; Foster D; Lasser G; Prunkard DE; Porte D; Woods SC; Seeley RJ; Weigle DS
Diabetes; 1996 Apr; 45(4):531-5. PubMed ID: 8603777
[TBL] [Abstract][Full Text] [Related]
26. v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats.
Maier VH; Melvin DR; Lister CA; Chapman H; Gould GW; Murphy GJ
Diabetes; 2000 Apr; 49(4):618-25. PubMed ID: 10871200
[TBL] [Abstract][Full Text] [Related]
27. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE
Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404
[TBL] [Abstract][Full Text] [Related]
28. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes.
Matsuda J; Hosoda K; Itoh H; Son C; Doi K; Hanaoka I; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Odaka H; Nakao K
Diabetes; 1998 Nov; 47(11):1809-14. PubMed ID: 9792555
[TBL] [Abstract][Full Text] [Related]
29. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice.
Chang AY; Wyse BM; Gilchrist BJ
Diabetes; 1983 Sep; 32(9):839-45. PubMed ID: 6354791
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice.
Moore GB; Chapman H; Holder JC; Lister CA; Piercy V; Smith SA; Clapham JC
Biochem Biophys Res Commun; 2001 Aug; 286(4):735-41. PubMed ID: 11520059
[TBL] [Abstract][Full Text] [Related]
31. Direct effects of leptin on brown and white adipose tissue.
Siegrist-Kaiser CA; Pauli V; Juge-Aubry CE; Boss O; Pernin A; Chin WW; Cusin I; Rohner-Jeanrenaud F; Burger AG; Zapf J; Meier CA
J Clin Invest; 1997 Dec; 100(11):2858-64. PubMed ID: 9389752
[TBL] [Abstract][Full Text] [Related]
32. In Zucker diabetic fatty rats plasma leptin levels are correlated with plasma insulin levels rather than with body weight.
Janssen SW; Martens GJ; Sweep CG; Ross HA; Hermus AR
Horm Metab Res; 1999 Nov; 31(11):610-5. PubMed ID: 10598829
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
[TBL] [Abstract][Full Text] [Related]
34. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue.
Vidal H; Auboeuf D; De Vos P; Staels B; Riou JP; Auwerx J; Laville M
J Clin Invest; 1996 Jul; 98(2):251-5. PubMed ID: 8755631
[TBL] [Abstract][Full Text] [Related]
35. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
[TBL] [Abstract][Full Text] [Related]
36. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
[TBL] [Abstract][Full Text] [Related]
37. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice.
Stevenson RW; Hutson NJ; Krupp MN; Volkmann RA; Holland GF; Eggler JF; Clark DA; McPherson RK; Hall KL; Danbury BH
Diabetes; 1990 Oct; 39(10):1218-27. PubMed ID: 2210074
[TBL] [Abstract][Full Text] [Related]
38. Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice.
Liang Y; Chen X; Osborne M; DeCarlo SO; Jetton TL; Demarest K
Diabetes Obes Metab; 2005 Jul; 7(4):360-9. PubMed ID: 15955122
[TBL] [Abstract][Full Text] [Related]
39. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
Vidal-Puig A; Jimenez-Liñan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE
J Clin Invest; 1996 Jun; 97(11):2553-61. PubMed ID: 8647948
[TBL] [Abstract][Full Text] [Related]
40. Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse.
Tang Y; Osawa H; Onuma H; Nishimiya T; Ochi M; Sugita A; Makino H
Diabetes Res Clin Pract; 2001 Dec; 54(3):145-55. PubMed ID: 11689269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
